U.S. Markets closed

Kindred Biosciences, Inc. (KIN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
9.25+0.01 (+0.11%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close9.24
Bid0.00 x 2900
Ask0.00 x 800
Day's Range9.24 - 9.26
52 Week Range3.46 - 9.28
Avg. Volume1,529,032
Market Cap419.308M
Beta (5Y Monthly)1.32
PE Ratio (TTM)N/A
EPS (TTM)-0.22
Earnings DateMay 11, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.50
  • Benzinga

    3 Stocks Insiders Are Buying

    When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform. Primoris Services The Tr


    INVESTIGATION: Halper Sadeh LLP Investigates SYKE, MCF, ONEM, KIN; Shareholders are Encouraged to Contact the Firm

    NEW YORK, NY / ACCESSWIRE / August 17, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:Sykes Enterprises, Incorporated (NASDAQ:SYKE)concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Sitel Group for $54. If you are a Sykes shareholder, click here to learn more about your rights and options.

  • PR Newswire

    SHAREHOLDER ALERT: WeissLaw LLP Reminds KIN, SYKE, MNR, and QTS Shareholders About Its Ongoing Investigations

    If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: